Africa CDC - LSHTM MRC International Statistics & Epidemiology Group Partnership to Support Robust Analysis of COVID-19 Seroprevalence Data in Africa

非洲疾病控制和预防中心（非洲疾控中心）正在支持非洲联盟成员国开展全国调查，以确定具有SARS-CoV-2抗体的人口百分比，SARS-CoV-2是导致COVID-19的病毒。17个国家已经完成或正在进行第一轮调查，它们已同意分享数据，以便进行综合分析。该项目将聘请一名医学统计学家来管理和分析这一复杂的多国COVID-19调查数据，就调查设计和分析问题向国家级团队提供建议，并最终确定数据库，以便用于未来的研究。这些时间紧迫的分析结果将用于为国家和大陆一级的快速反应预防规划、政策和实践提供信息。此外，统计学家将为非洲疾控中心工作人员提供在职培训和指导，加强机构进行统计分析和解释调查结果的能力。他们最初将被雇用六个月，但将确定进一步的资金，以延长该职位的期限，并确保可持续地加强非洲疾病预防控制中心的生物统计能力。

Africa Centres for Disease Control and Prevention (Africa CDC) is supporting African Union Member States to conduct national surveys to determine the percentage of people who have antibodies against SARS-CoV-2, the virus that causes COVID-19. Seventeen countries have completed or are currently conducting the first round of these surveys, and they have agreed to share their data to enable combined analysis. This project will employ a medical statistician to manage and analyse this complex multi-country COVID-19 survey data, advise country-level teams on survey design and analysis issues, and finalise the database so that it can be used for future research. The results of these time-critical analyses will be used to inform rapid response prevention planning, policy, and practice at country and continental level. In addition, the statistician will provide on-the-job training and mentoring to Africa CDC staff, strengthening institutional capacity to conduct statistical analyses and interpret findings. They will initially be employed for six months, but further funding will be identified to extend the duration of the post and to ensure sustainable strengthening of biostatistical capacity at Africa CDC.